2024, Vol 14, No. 6

Editor-in-Chief

Prof. Khosro Adibkia

Original Research

1. An in vitro ethnopharmacological study on Prangos ferulacea: a wound healing agent

Keyvan Yousefi, Sanaz Hamedeyazdan, Darya Hodaei, Farzaneh Lotfipour, Behzad Baradaran, Mona Orangi, Fatemeh Fathiazad*

Bioimpacts. 2017;7(2): 75-82. doi: 10.15171/bi.2017.10

PMCID: PMC5524988 PMID: 28752071 Scopus ID: 85027462494

Article

PDF

Full Text

XML

Cited By:

Original Research

2. CRISPRi-mediated knock-down of PRDM1/BLIMP1 programs central memory differentiation in ex vivo-expanded human T cells

Mohammad Azadbakht , Ali Sayadmanesh, Naghme Nazer, Amirhossein Ahmadi, Sara Hemmati, Hoda Mohammadzade, Marzieh Ebrahimi, Hossein Baharvand, Babak Khalaj, Mahmoud Reza Aghamaali* , Mohsen Basiri*

BioImpacts. 2022;12(4): 337-347. doi: 10.34172/bi.2021.23522

PMCID: PMC9376159 PMID: 35975204 Scopus ID: 85137404752

Article

PDF

Suppl 1

Full Text

XML

Cited By:

PRDM1/BLIMP1 expression is increased during differentiation from naïve to effector T cell.CRISPRi-mediated suppression of this transcription factor in ex vivo-expanded primary human T cellsresulted in increased central memory phenotype in human T cells.

Original Article

3. Autophagy induced macrophages by α-alumina(α-AL2O3) conjugated cysteine peptidase, enhances the cytotoxic activity of CD8+ T lymphocytes against Leishmania major

Fatemeh Beyzay , Ahamad Zavaran Hosseini* , Ali Hazrati, Mozhdeh Karimi, Sara Soudi*

Bioimpacts. 2023;13(5): 393-403. doi: 10.34172/bi.2023.25282

PMCID: PMC10509742 PMID: 37736336 Scopus ID: 85172771576

Article

PDF

Full Text

XML

Cited By:

Review

4. The application, safety, and future of ex vivo immune cell therapies and prognosis in different malignancies

Katelyn R. Einloth , Scott Gayfield, Thomas McMaster, Alexander Didier, Lance Dworkin, Justin Fortune Creeden*

Bioimpacts. 2023;13(6): 439-455. doi: 10.34172/bi.2023.27521

PMCID: PMC10676524 PMID: 38022382 Scopus ID: 85172806877

Article

PDF

Full Text

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons